• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B值:一种数据监测工具。

The B-value: a tool for monitoring data.

作者信息

Lan K K, Wittes J

机构信息

Biostatistics Research Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

出版信息

Biometrics. 1988 Jun;44(2):579-85.

PMID:3390511
Abstract

This paper considers the problem of monitoring slowly accruing data from a nonsequentially designed experiment. We describe the use of the B-value, which is a transformed Z-value, for the calculation of conditional power. In data monitoring, interim Z-values do not allow simple projections to the end of the study. Moreover, because of their popular association with P-values, Z-values are often misinterpreted. If observed trends are viewed as the realization of a Brownian motion process, the B-value and its decomposition allow simple extrapolations to the end of the study under a variety of hypotheses. Applications are presented to one- and two-sample Z-tests, the two-sample Wilcoxon rank sum test, and the log-rank test.

摘要

本文考虑了监测来自非序贯设计实验的缓慢积累数据的问题。我们描述了使用B值(它是一种变换后的Z值)来计算条件功效。在数据监测中,中期Z值不允许简单地推算到研究结束。此外,由于它们与P值密切相关,Z值常常被误解。如果将观察到的趋势视为布朗运动过程的实现,那么在各种假设下,B值及其分解允许简单地推算到研究结束。文中给出了单样本和两样本Z检验、两样本Wilcoxon秩和检验以及对数秩检验的应用。

相似文献

1
The B-value: a tool for monitoring data.B值:一种数据监测工具。
Biometrics. 1988 Jun;44(2):579-85.
2
Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.基于序贯条件概率比检验和反向随机截尾的临床试验设计。
Biometrics. 1998 Jun;54(2):682-95.
3
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.使用期中 Z 值或置信限控制 I 型和 II 型错误概率的无效性期中监测。
Clin Trials. 2009 Dec;6(6):565-73. doi: 10.1177/1740774509350327. Epub 2009 Nov 23.
4
A review of methods for futility stopping based on conditional power.基于条件功效的无效性终止方法综述。
Stat Med. 2005 Sep 30;24(18):2747-64. doi: 10.1002/sim.2151.
5
Optimal conditional error functions for the control of conditional power.用于控制条件功效的最优条件误差函数。
Biometrics. 2004 Sep;60(3):715-23. doi: 10.1111/j.0006-341X.2004.00221.x.
6
Designed extension of studies based on conditional power.基于条件效能对研究进行的设计扩展。
Biometrics. 1995 Dec;51(4):1315-24.
7
Evaluation of experiments with adaptive interim analyses.自适应期中分析实验的评估。
Biometrics. 1994 Dec;50(4):1029-41.
8
A note on P-values under group sequential testing and nonproportional hazards.关于成组序贯检验和非比例风险下的P值的注释
Biometrics. 2005 Jun;61(2):546-51. doi: 10.1111/j.1541-0420.2005.040342.x.
9
Assessment of futility in clinical trials.临床试验中无效性的评估。
Pharm Stat. 2006 Oct-Dec;5(4):273-81. doi: 10.1002/pst.216.
10
Increasing the sample size when the unblinded interim result is promising.当非盲法中期结果有希望时增加样本量。
Stat Med. 2004 Apr 15;23(7):1023-38. doi: 10.1002/sim.1688.

引用本文的文献

1
Monitoring Ongoing Clinical Trials under Fractional Brownian Motion with Drift.基于带漂移的分数布朗运动监测正在进行的临床试验。
Stat Biopharm Res. 2025;17(1):102-112. doi: 10.1080/19466315.2024.2327290. Epub 2024 Apr 15.
2
Group Sequential Test for Two-Sample Ordinal Outcome Measures.两样本有序结局指标的序贯检验
Stat Med. 2025 Mar 15;44(6):e70053. doi: 10.1002/sim.70053.
3
Improving the Effectiveness of Sample Size Re-Estimation: An Operating Characteristic Focused, Hybrid Frequentist-Bayesian Approach.提高样本量重新估计的有效性:一种以操作特征为重点的混合频率主义-贝叶斯方法。
Stat Med. 2025 Feb 10;44(3-4):e10310. doi: 10.1002/sim.10310.
4
Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic: A review.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行期间中断的临床试验的统计方法:综述。
Stat Methods Med Res. 2024 Nov;33(11-12):2131-2143. doi: 10.1177/09622802241288350. Epub 2024 Oct 30.
5
Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness.用于避免低血糖和纠正低血糖感知障碍的 1 型糖尿病患者的血糖自动化输注。
Diabetes Technol Ther. 2023 May;25(5):302-314. doi: 10.1089/dia.2022.0506. Epub 2023 Feb 24.
6
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.舒巴坦匹酯或环丙沙星治疗女性单纯性尿路感染的随机对照 3 期临床试验
Clin Infect Dis. 2023 Jan 6;76(1):66-77. doi: 10.1093/cid/ciac738.
7
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study.一项局部晚期胰腺癌诱导化疗后同步放化疗的 II 期随机试验:台湾癌症协作组 T2212 研究。
Br J Cancer. 2022 Apr;126(7):1018-1026. doi: 10.1038/s41416-021-01649-7. Epub 2021 Dec 17.
8
Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines.评估 2019 冠状病毒病疫苗的效力。
Clin Infect Dis. 2021 Oct 20;73(8):1540-1544. doi: 10.1093/cid/ciaa1863.
9
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial.四种剂量维生素D补充剂对老年人跌倒的影响:一项适应性随机临床试验
Ann Intern Med. 2021 Feb;174(2):145-156. doi: 10.7326/M20-3812. Epub 2020 Dec 8.
10
Futility stopping in clinical trials, optimality and practical considerations.临床试验中的无效停止、最优性和实际考虑。
J Biopharm Stat. 2020 Nov 1;30(6):1050-1059. doi: 10.1080/10543406.2020.1818253. Epub 2020 Sep 14.